Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Randomized Phase 2 Study of Nivolumab and Ipilimumab with or without Cabozantinib in Patients with Advanced Nasopharyngeal Carcinoma that have Progressed after Platinum Treatment with Immunotherapy

Head/Neck

A Phase II Trial Evaluating Chemotherapy Followed by Response-Based Reduced Radiation Therapy for Patients with Central Nervous System Germinomas

Phase 3 Multicenter, Randomized, Open-Label, Active-Controlled Study of Sotorasib, Panitumumab and FOLFIRI versus FOLFIRI with or without Bevacizumab-awwb for Treatment-Nave Subjects with Metastatic Colorectal Cancer with KRAS p.G12C Mutation (CodeBreaK 301)

IMPACT: A Clinical Investigation on Improving Peripheral Neuropathy Induced by Chemotherapy with Advanced Compression Technology - A Safety and Efficacy Study

Miscellaneous

A Randomized, Double-blinded, Multiregional Phase 3 Study of Ivonescimab Versus Pembrolizumab for the First-line Treatment of Metastatic Non-small Cell Lung Cancer in Patients Whose Tumors Demonstrate High PD-L1 Expression (TPS >= 50%) (HARMONi-7).

A Phase 2, Open-Label, Randomized, Multicenter Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease

Precision Diagnostics in Prostate Cancer Treatment (PREDICT)

ANBL2131: A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma

Endoscopic Gastroenterostomy Versus Surgical Gastrojejunostomy for Treatment of Malignant Gastric Outlet Obstruction: A Randomized Controlled Trial

Gastrointestinal

AHOD2131: A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy with Immuno-Oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma

Multiple Cancer Types